Memantine Hydrochloride recalls
Memantine Hydrochloride products have been recalled 2 times, most recently on 19 Feb 2020. The recalling company is usually Lupin Pharmaceuticals. The most common reason is potency & assay.
Total recalls2since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 19 Feb 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why memantine hydrochloride is recalled
Companies
By year
All memantine hydrochloride recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Memantine Hydrochloride Extended Release Capsules, 21 mg recalledMemantine Hydrochloride | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS III | Memantine Hydrochloride Extended-release Capsules, 28mg recalledMemantine Hydrochloride | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.